Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by barmac6on Feb 08, 2011 9:47am
182 Views
Post# 18093015

Wellington

WellingtonWellington just can't seem to get enough!


House Positions for HEM from 20110208 to 20110208

Ex House Bought $Value Ave Sold $Value Ave Net $Net
12 Wellington 202,500 306,675 1.51 0 202,500 -306,675
7 TD Sec 42,300 64,225 1.52 18,100 27,228 1.50 24,200 -36,997
9 BMO Nesbitt 11,000 16,870 1.53 5,000 7,620 1.52 6,000 -9,250
58 Qtrade 2,500 3,750 1.50 0 2,500 -3,750
6 Union 1,000 1,560 1.56 0 1,000 -1,560
124 Questrade 400 600 1.50 0 400 -600
99 Jitney 0 1,000 1,505 1.51 -1,000 1,505
2 RBC 7,500 11,340 1.51 10,000 15,000 1.50 -2,500 3,660
1 Anonymous 5,000 7,505 1.50 13,000 19,530 1.50 -8,000 12,025
62 Haywood 0 20,000 30,400 1.52 -20,000 30,400
80 National Bank 0 20,000 30,600 1.53 -20,000 30,600
85 Scotia 3,000 4,510 1.50 25,000 38,250 1.53 -22,000 33,740
59 PI 0 50,000 75,000 1.50 -50,000 75,000
14 ITG 0 56,400 86,292 1.53 -56,400 86,292
79 CIBC 5,000 7,560 1.51 61,700 93,170 1.51 -56,700 85,610
Total 280,200 424,595 1.52 280,200 424,595 1.52 0 0
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse